Cargando…

Preventative medicine and Alzheimer’s disease: is Alzheimer’s disease risk reduction achievable?

Detalles Bibliográficos
Autores principales:	Sinyor, Benjamin, Isaacson, Richard, Ochner, Christopher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328765/ https://www.ncbi.nlm.nih.gov/pubmed/33510071 http://dx.doi.org/10.4103/1673-5374.306086

Ejemplares similares

Alzheimer’s Disease, Inflammation, and the Role of Antioxidants
por: Sinyor, Benjamin, et al.
Publicado: (2020)

Precision Nutrition for Alzheimer’s Prevention in ApoE4 Carriers
por: Norwitz, Nicholas G., et al.
Publicado: (2021)

Precision Medicine for Alzheimer’s Disease Prevention
por: Berkowitz, Cara L., et al.
Publicado: (2018)

The pathway to secondary prevention of Alzheimer's disease
por: McDade, Eric, et al.
Publicado: (2020)

Mechanisms of Risk Reduction in the Clinical Practice of Alzheimer’s Disease Prevention
por: Schelke, Matthew W., et al.
Publicado: (2018)

Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study
por: Desai, Rishi J., et al.
Publicado: (2020)

Finding effective combinations of compounds to prevent Alzheimer’s disease
por: Dhakal, Sudip, et al.
Publicado: (2022)

The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease
por: Lopez Lopez, Cristina, et al.
Publicado: (2019)

The clinical practice of risk reduction for Alzheimer’s disease: A precision medicine approach
por: Isaacson, Richard S., et al.
Publicado: (2018)

Repurposing verapamil for prevention of cognitive decline in sporadic Alzheimer's disease
por: Ahmed, Heba A., et al.
Publicado: (2021)

Alzheimer's disease in Down syndrome: An overlooked population for prevention trials
por: Strydom, André, et al.
Publicado: (2018)

Biomarker-guided drug therapy: personalized medicine for treating Alzheimer’s disease
por: Syal, Charvi, et al.
Publicado: (2021)

Precision medicine: Clarity for the clinical and biological complexity of Alzheimer’s and Parkinson’s diseases
por: Montine, Thomas J., et al.
Publicado: (2015)

New approaches for prevention and treatment of Alzheimer's disease: a fascinating challenge
por: Piemontese, Luca
Publicado: (2017)

Determining the mechanism behind yoga’s effects on preventing the symptoms of Alzheimer’s disease
por: Hassan, Adithy, et al.
Publicado: (2019)

Advancing combination therapy for Alzheimer's disease
por: Salloway, Stephen P., et al.
Publicado: (2020)

Endocannabinoid metabolism and Alzheimer's disease
por: Chen, Chu
Publicado: (2022)

OxInflammation in Alzheimer’s disease
por: Cervellati, Carlo, et al.
Publicado: (2023)

Rationale and design of the ABOARD project (A Personalized Medicine Approach for Alzheimer's Disease)
por: Dreves, Maria A. E., et al.
Publicado: (2023)

Detrimental and synergistic role of epilepsy – Alzheimer’s disease risk factors
por: Filippov, Mikhail A., et al.
Publicado: (2019)

Abscisic acid, a promising therapeutic molecule to prevent Alzheimer’s and neurodegenerative diseases
por: Sánchez-Pérez, Ana María
Publicado: (2019)

Probiotics, prebiotics and their role in Alzheimer’s disease
por: D'Argenio, Valeria, et al.
Publicado: (2021)

Next generation therapeutics for Alzheimer's disease
por: Bredesen, Dale E, et al.
Publicado: (2013)

New Approaches to Treating Alzheimer’s Disease
por: Zheng, Hailin, et al.
Publicado: (2015)

Alzheimer’s Disease is a Disorder of Consciousness
por: Yokoi, Teruo
Publicado: (2023)

Open drug discovery in Alzheimer's disease
por: Axtman, Alison D., et al.
Publicado: (2023)

Reevaluating the cause of laminopathy in Alzheimer’s disease
por: Islam, Md Imamul, et al.
Publicado: (2023)

Translational animal models for Alzheimer's disease: An Alzheimer's Association Business Consortium Think Tank
por: Vitek, Michael P., et al.
Publicado: (2021)

Impact of COVID-19 on Alzheimer’s Disease Risk: Viewpoint for Research Action
por: Abate, Giulia, et al.
Publicado: (2020)

Supplemental thiamine as a practical, potential way to prevent Alzheimer's disease from commencing
por: Fessel, Jeffrey
Publicado: (2021)

A vaccine to prevent initial loss of cognition and eventual Alzheimer's disease in elderly persons
por: Fessel, Jeffrey
Publicado: (2021)

Health economic modeling for Alzheimer's disease: Expert perspectives
por: Landeiro, Filipa, et al.
Publicado: (2022)

Sex, ApoE4 and Alzheimer’s disease: rethinking drug discovery in the era of precision medicine
por: Paranjpe, Manish D., et al.
Publicado: (2021)

Active immunotherapy and alternative therapeutic modalities for Alzheimer's disease
por: Weninger, Stacie, et al.
Publicado: (2020)

Measuring cognition and function in the preclinical stage of Alzheimer's disease
por: Weintraub, Sandra, et al.
Publicado: (2018)

Deuterated dextromethorphan/quinidine for agitation in Alzheimer's disease
por: Khoury, Rita
Publicado: (2021)

Understanding Alzheimer's disease as a disorder of consciousness
por: Huntley, Jonathan D., et al.
Publicado: (2021)

Brain ischemia as a bridge to Alzheimer’s disease
por: Pluta, Ryszard
Publicado: (2021)

Insufficient evidence for vitamin E in Alzheimer's disease
por: Hermann, Dirk M.
Publicado: (2016)

Dementia in the oldest old: Beyond Alzheimer disease
por: Pierce, Aimee L., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lp64eqjk4hnul7ja39dj45dfcd